Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04257695 · ClinicalTrials.gov registry record · NA
Developing and Pilot Testing an Opioid Tapering Protocol
A NA study, sponsored by Albert Einstein College of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT04257695 is a NA study that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 2 participants.
The verdict
NCT04257695, a NA study, has completed, sponsored by Albert Einstein College of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
This study proposes to pilot test an intervention to facilitate opioid pain reliever (OPR) tapering in primary care. The intervention will incorporate a clinician embedded within primary care to follow tapering dose schedules to support providers as well to deliver a psychosocial curriculum to support and engage patients. In a pilot randomized controlled trial (RCT), the study will examine the preliminary efficacy and feasibility of the manualized, protocol-based tapering intervention ("TapPro") compared to usual care. As there is no standard definition or outcome for tapering, the primary efficacy outcome is a decrease in OPR dose over six months. Separately, the study proposes a clinically meaningful dose reduction (greater than or equal to 30 percent) as a secondary outcome. The central hypotheses' are that a tapering intervention with patient and provider support is feasible in a primary care setting and can result in greater dose reduction when compared to usual care.
Interventions
- BEHAVIORAL TapPro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2021-05-04 |
| Est. Completion | 2023-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04257695
The ClinicalTrials.gov registry entry for NCT04257695 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TapPro is the first listed.
NCT04257695 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04257695 about?
NCT04257695 is a clinical study titled "Developing and Pilot Testing an Opioid Tapering Protocol". This study proposes to pilot test an intervention to facilitate opioid pain reliever (OPR) tapering in primary care. The intervention will incorporate a clinician embedded within primary care to follow tapering dose schedules to support providers as well to deliver a psychosocial curriculum to suppo...
What is the current status of trial NCT04257695?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2021-05-04. Estimated completion is 2023-08-31.
What interventions are being tested in trial NCT04257695?
The interventions under investigation include: TapPro (BEHAVIORAL).
Who is sponsoring clinical trial NCT04257695?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.